Literature DB >> 20587253

Assessing Prognosis of Areas of Acute Cerebral Ischemia Using Perfusion CT.

M Hayakawa1, M Negoro, H Toyama, K Irie, S Imizu, K Iritani, J Hayashi, Y Idesawa, K Katada, T Kanno.   

Abstract

SUMMARY: Vascular recanalization by the vascular reconstruction method can dramatically improve ischemic symptoms in patients with acute cerebral ischemia. However, this treatment method is frequently associated with haemorrhagic complications. The indications for this therapeutic approach have been described in a number of studies in the literature. The present paper discusses the possibility of assessing the prognosis of ischemic areas using perfusion CT (PCT) by comparing the results obtained before and after thrombolytic therapy. Twenty-six patients underwent vascular reconstruction at our hospital between July 2002 and March 2004. Of these patients, six who underwent PCT before treatment and showed adequate recanalization following vascular reconstruction were included in the present study. PCT images were obtained using the first-pass bolus-tracking method with a 16-row multislice helical CT scanner. Areas of cerebral ischemia were evaluated by CT before and after vascular reconstruction. A region of interest was placed in the area showing low density in CT images before vascular reconstruction. The mean average CBF (mL/min/100 g), CBV (mL/100 g), and MTT (s) values were calculated in areas with and without cerebral infarction after vascular reconstruction. The %CBF, % CBV, and %MTT values relative to the normal side were evaluated with reference to the time until recanalization. Transarterial vascular reconstruction resulted in full recanalization in four patients and partial recanalization in two. The mean time from onset to recanalization was 284.7 +/- 63.27 minutes and was not longer than six hours in any patient. The patient prognosis results in terms of GOS were GR in two patients, MD in three patients, and SD in one patient. Based on comparison of the time after examination to recanalization, the %CBF showed a significant positive correlation in the salvaged area (Y = 47.321 + 2.491 x %CBF:R(2) = 0.792, p < 0.05). A significant correlation was not observed in %CBV, but %MTT showed a significant negative correlation (Y = 269.45 - 0.356 x %MTT:R(2) = 0.794, p < 0.05). The %CBF and %MTT results obtained by PCT performed before transarterial vascular reconstruction suggest that it may be possible to estimate the time before vascular reconstruction and the relationship with prognosis. These findings are expected to help ensure the appropriate application of vascular reconstruction and to provide useful information for developing optimal therapeutic protocols, thus reducing complications. In addition, because the results are based on the time after examination, the appropriate therapeutic approach can be determined even when the time of onset of ischemia is uncertain.

Entities:  

Year:  2008        PMID: 20587253      PMCID: PMC3522225          DOI: 10.1177/15910199040100S214

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  19 in total

1.  Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy.

Authors:  J L Sunshine; R W Tarr; C F Lanzieri; D M Landis; W R Selman; J S Lewin
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

2.  Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome.

Authors:  M H Lev; A Z Segal; J Farkas; S T Hossain; C Putman; G J Hunter; R Budzik; G J Harris; F S Buonanno; M A Ezzeddine; Y Chang; W J Koroshetz; R G Gonzalez; L H Schwamm
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

Review 3.  Computed tomographic angiography and computed tomographic perfusion imaging of hyperacute stroke.

Authors:  M H Lev; S J Nichols
Journal:  Top Magn Reson Imaging       Date:  2000-10

4.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

5.  Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients.

Authors:  Max Wintermark; Marc Reichhart; Jean-Philippe Thiran; Philippe Maeder; Marc Chalaron; Pierre Schnyder; Julien Bogousslavsky; Reto Meuli
Journal:  Ann Neurol       Date:  2002-04       Impact factor: 10.422

6.  Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.

Authors:  M P Marks; D C Tong; C Beaulieu; G W Albers; A de Crespigny; M E Moseley
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

7.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.

Authors:  C S Kidwell; J L Saver; J Mattiello; S Starkman; F Vinuela; G Duckwiler; Y P Gobin; R Jahan; P Vespa; M Kalafut; J R Alger
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

8.  Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging.

Authors:  O Wu; W J Koroshetz; L Ostergaard; F S Buonanno; W A Copen; R G Gonzalez; G Rordorf; B R Rosen; L H Schwamm; R M Weisskoff; A G Sorensen
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

9.  Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography.

Authors:  T Ueda; S Sakaki; W T Yuh; I Nochide; S Ohta
Journal:  J Cereb Blood Flow Metab       Date:  1999-01       Impact factor: 6.200

10.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.

Authors:  R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.